Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Connors

Showing results (11-20 of 977) with videos related to

Pageof 98
Sort By:
Important Advances in Oncology|January 1, 1990
The clinician's decision of whether CHOP chemotherapy should be standard therapy for treatment of patients with diffuse histiocytic lymphomaJ M Connors
The New England Journal of Medicine|February 22, 2013
Extended treatment of venous thromboembolismJean M Connors
Progress in Clinical and Biological Research|January 1, 1990
Induction of secondary neoplasms by the treatment of malignant disease: lessons from Hodgkin's diseaseJ M Connors
Blood|December 21, 2013
Treatment of NLPHLJoseph M Connors
Circulation. Heart Failure|May 8, 2016
On Target: Optimum International Normalized Ratio for Left Ventricular Assist Device PatientsJean M Connors
The New England Journal of Medicine|September 21, 2017
Thrombophilia Testing and Venous ThrombosisJean M Connors
European Heart Journal|July 12, 2024
Thrombotic risks associated with COVID-19 vaccination in atrial fibrillation or atrial flutter: no reason for alarmJean M Connors
Blood|January 18, 2014
Preventing pregnancy lossJean M Connors
Current Hematologic Malignancy Reports|May 20, 2014
Chemotherapy only in early stage Hodgkin lymphoma: more relapses but the same survival--what to do?Joseph M Connors
European Heart Journal|September 21, 2021
Thromboinflammatory findings and clinical predictors of mortality in vaccine-induced immune thrombotic thrombocytopeniaJean M Connors
Pageof 98

Showing results (11-20 of 977) with videos related to

Sort By:
Pageof 98
Important Advances in Oncology|January 1, 1990
The clinician's decision of whether CHOP chemotherapy should be standard therapy for treatment of patients with diffuse histiocytic lymphomaJ M Connors
The New England Journal of Medicine|February 22, 2013
Extended treatment of venous thromboembolismJean M Connors
Progress in Clinical and Biological Research|January 1, 1990
Induction of secondary neoplasms by the treatment of malignant disease: lessons from Hodgkin's diseaseJ M Connors
Blood|December 21, 2013
Treatment of NLPHLJoseph M Connors
Circulation. Heart Failure|May 8, 2016
On Target: Optimum International Normalized Ratio for Left Ventricular Assist Device PatientsJean M Connors
The New England Journal of Medicine|September 21, 2017
Thrombophilia Testing and Venous ThrombosisJean M Connors
European Heart Journal|July 12, 2024
Thrombotic risks associated with COVID-19 vaccination in atrial fibrillation or atrial flutter: no reason for alarmJean M Connors
Blood|January 18, 2014
Preventing pregnancy lossJean M Connors
Current Hematologic Malignancy Reports|May 20, 2014
Chemotherapy only in early stage Hodgkin lymphoma: more relapses but the same survival--what to do?Joseph M Connors
European Heart Journal|September 21, 2021
Thromboinflammatory findings and clinical predictors of mortality in vaccine-induced immune thrombotic thrombocytopeniaJean M Connors
Pageof 98